Biopolym. Cell. 2016; 32(5):381-394.
http://dx.doi.org/10.7124/bc.000934
Discussions
Modelling of systemic lesion of organism for development of multitarget cellular and cytokine therapy
1, 2Kordium V. A., 3Chaikovsky Yu. B., 1Irodov D. M., 2Drahulian M. V., 2Gulko T. P., 2Buchek P. V., 3Korsak A. V., 3Neverovskiy A. V.
  1. State Institute of Genetic and Regenerative Medicine, NAMS of Ukraine
    67, Vyshhorodska Str., Kyiv, Ukraine, 04114
  2. Institute of Molecular Biology and Genetics, NAS of Ukraine
    150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680
  3. Bogomolets National Medical University
    13, Shevchenko Blvd., Kyiv, Ukraine, 01601

Abstract

In recent decades many human pathologies have taken a chronic course. Modern biology and medicine have come to conceptually new therapeutic approaches. The technologies, comprising stem cells and signaling molecules, are the most promising in this respect. They have a potential of restoring systemic lesions, which are the basis of chronicity. To develop these approaches, an adequate and realizable model is required. Here we present an attempt of elaborating such a murine model using CCl4 as an agent, causing systemic lesions.
Keywords: CCl4, stem cells, systemic lesion, model organism, cellular and cytokine therapy
Full text: (PDF, in English)

References

[1] Recknagel RO, Glende EA Jr, Dolak JA, Waller RL. Mechanisms of carbon tetrachloride toxicity. Pharmacol Ther. 1989;43(1):139-54. Review.
[2] McGregor D, Lang M. Carbon tetrachloride: genetic effects and other modes of action. Mutat Res. 1996;366(3):181-95. Review.
[3] Manibusan MK, Odin M, Eastmond DA. Postulated carbon tetrachloride mode of action: a review. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2007;25(3):185-209. Review.
[4] Weber LW, Boll M, Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol. 2003;33(2):105-36. Review.
[5] Brattin WJ, Glende EA Jr, Recknagel RO. Pathological mechanisms in carbon tetrachloride hepatotoxicity. J Free Radic Biol Med. 1985;1(1):27-38. Review.
[6] Kordium VA, Shuvalova NS. The concept of «origin» – problem definition and attempt of analysis. Biopolym Cell. 2013; 29(5):428–40.
[7] Basu S. Carbon tetrachloride-induced lipid peroxidation: eicosanoid formation and their regulation by antioxidant nutrients. Toxicology. 2003;189(1-2):113-27. Review.
[8] Geerts AM, Vanheule E, Praet M, Van Vlierberghe H, De Vos M, Colle I. Comparison of three research models of portal hyper-tension in mice: macroscopic, histological and portal pressure evaluation. Int J Exp Pathol. 2008;89(4):251–63.
[9] Constandinou C, Henderson N, Iredale JP. Modeling liver fibrosis in rodents. Methods Mol Med. 2005;117:237-50.
[10] Marques TG, Chaib E, da Fonseca JH, Lourenço AC, Silva FD, Ribeiro MA Jr, Galvão FH, D'Albuquerque LA. Review of experimental models for inducing hepatic cirrhosis by bile duct ligation and carbon tetrachloride injection. Acta Cir Bras. 2012;27(8):589-94. Review.
[11] Das M, Boerma M, Goree JR, Lavoie EG, Fausther M, Gubrij IB, Pangle AK, Johnson LG, Dranoff JA. Pathological changes in pulmonary circulation in carbon tetrachloride (CCl4)-induced cirrhotic mice. PLoS One. 2014;9(4):e96043.
[12] Ganie SA, Haq E, Hamid A, Qurishi Y, Mahmood Z, Zargar BA, Masood A, Zargar MA. Carbon tetrachloride induced kidney and lung tissue damages and antioxidant activities of the aqueous rhizome extract of Podophyllum hexandrum. BMC Complement Altern Med. 2011;11:17.
[13] Das M, Fessel J, Tang H, West J. A process-based review of mouse models of pulmonary hypertension. Pulm Circ. 2012;2(4):415-33.